3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
16
Colorectal Neoplasms
7
Small Cell Lung Carcinoma
4
Neoplasm Metastasis
4
Stomach Neoplasms
3
Recurrence
3
Biliary Tract Neoplasms
3
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Fallopian Tube Neoplasms
2
Cholangiocarcinoma
2
Triple Negative Breast Neoplasms
1
Somatostatinoma
1
Solid Tumor
1
Small Cell Lung Cancer Extensive Stage
1
Small Bowel Adenocarcinoma
1
Rectal Neoplasms
1
Rectal Cancer Patients
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Cancer Non-resectable
1
Pancreatic Cancer Metastatic to Liver
1
Pancreatic Adenocarcinoma
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Osteosarcoma
1
Neoplasms
1
Neoadjuvant Chemotherapy
1
Metastatic Pancreatic Adenocarcinoma
1
Locally Advanced Rectal Cancer (LARC)
1
Interventions
irinotecan sucrosofate
1
Oxaliplatin
1
Fluorouracil
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neoadjuvant Chemotherapy
×
irinotecan sucrosofate
×
Clear all
NCT06172036
2023-12-15
CAPT-02
Zhejiang University
Phase 2
Not yet recruiting
180 enrolled